Ownership and insider activity for ResMed Inc. (RMD): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service.
Price
| Price | $222.86 |
| Market Cap | $32.3B |
| Exchange | NYSE |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-08 | Farrell Michael J. | |||
| 2026-08-14 | Leong Justin | A-Award | 6,461 | |
| 2026-08-14 | Rider Michael J | A-Award | 3,230 | |
| 2026-08-14 | Farrell Michael J. | A-Award | 13,547 | |
| 2026-08-14 | Bloomer Aaron | A-Award | 9,072 | |
| 2026-09-08 | Farrell Michael J. | M-Exempt | 4,991 | $730K |
| 2026-09-08 | Farrell Michael J. | S-Sale | 4,991 | $1.1M |
| 2026-09-08 | Farrell Michael J. | M-Exempt | 4,991 | $730K |
| 2026-09-02 | FARRELL PETER C | S-Sale | 970 | $228K |
| 2026-08-07 | Farrell Michael J. | M-Exempt | 4,991 | $730K |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $821.9M | $188.7M | $147.1M | $463.2M | $295.3M | $273.7M | $227.9M | $238.4M | $1.21B | $1.47B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $450.5M | $483.7M | $528.5M | $474.6M | $625.2M | $576.0M | $704.9M | $837.3M | $990.7M | $1.04B |
| Inventory | $268.3M | $268.7M | $349.6M | $416.9M | $457.0M | $743.9M | $998.0M | $822.2M | $927.7M | $945.8M |
| Total Current Assets | $1.64B | $1.07B | $1.15B | $1.52B | $1.57B | $1.93B | $2.37B | $2.36B | $3.51B | $4.32B |
| Property, Plant & Equipment | $394.2M | $386.6M | $387.5M | $535.7M | $592.1M | $630.5M | $665.8M | $699.1M | $718.3M | $735.0M |
| Goodwill | $1.06B | $1.07B | $1.86B | $1.89B | $1.93B | $1.94B | $2.77B | $2.84B | $3.05B | $3.36B |
| Intangible Assets | $261.8M | $215.2M | $522.0M | $448.2M | $392.6M | $345.9M | $552.3M | $485.9M | $464.9M | 0 |
| Total Assets | $3.47B | $3.06B | $4.11B | $4.59B | $4.73B | $5.10B | $6.75B | $6.87B | $8.17B | $8.97B |
| Accounts Payable | $92.8M | $92.7M | $115.7M | $135.8M | $138.0M | $159.2M | $150.8M | $237.7M | $278.2M | $308.9M |
| Short-term Debt | 0 | $11.5M | $12.0M | $12.0M | $12.0M | $9.9M | $9.9M | $9.9M | $9.9M | $259.9M |
| Total Current Liabilities | $360.1M | $511.2M | $556.0M | $602.8M | $911.8M | $689.3M | $758.5M | $910.7M | $1.02B | $1.40B |
| Long-term Debt | $1.08B | $270.0M | $1.26B | $1.16B | $643.4M | $765.3M | $1.43B | $697.3M | $658.4M | $399.4M |
| Total Liabilities | $1.51B | $1.00B | $2.04B | $2.09B | $1.84B | $1.74B | $2.62B | $2.01B | $2.21B | $2.38B |
| Retained Earnings | $2.32B | $2.43B | $2.44B | $2.83B | $3.08B | $3.61B | $4.25B | $4.99B | $6.08B | $7.26B |
| Total Equity | $1.96B | $2.06B | $2.07B | $2.50B | $2.89B | $3.36B | $4.13B | $4.86B | $5.97B | $6.59B |
| Total Debt | $1.08B | $281.5M | $1.27B | $1.30B | $793.7M | $917.5M | $1.58B | $873.9M | $851.8M | $825.9M |
| Net Debt | $256.7M | $92.8M | $1.12B | $836.1M | $498.4M | $643.8M | $1.35B | $635.6M | -$357.6M | -$643.3M |
| Working Capital | $1.28B | $554.5M | $589.4M | $920.7M | $663.0M | $1.24B | $1.61B | $1.45B | $2.49B | $2.93B |
Financial Health
| Debt / Equity | 0.13 |
| Current Ratio | 3.10 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 9.96 |
Profitability
| Return on Equity | 23.13% |
| Return on Invested Capital | 19.11% |
| Return on Assets | 16.99% |
| Gross Margin | 61.16% |
| Operating Margin | 33.48% |
| Net Margin | 26.94% |
Related companies: A · ALC · BDX · CAH · GEHC · HLN · HUM
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of RMD: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks